Editorial Staff

Amar Sawhney on Sikhs, STEM & COVID

/in , , , , , , /by Editorial Staff
Share on Facebook
Share on Twitter
Share on
LinkedIn
+

The entrepreneurial spirit among immigrants and refugees allows them the flexibility to pursue unexpected courses of action, adapt, accept risk and make the most of opportunities they didn’t even know of before. For Dr. Amar Sawhney from India, that started at the University of Texas at Austin with 30 job rejections out of 30 applications. But he charted a path that would see him go in directions hitherto unknown to him: getting a PhD, helping found a company, journeying to Boston, and starting a string of new companies, using his chemical engineering background to save lives through remarkable local therapy innovations. To date, he has founded eight companies accounting for 4,000 jobs and more than $2 billion in revenue. He’s been named a “Champion of Change” by The White House, one of the “five most innovative Medical Device CEOs” by MassDevice, the EY regional entrepreneur of the year, The Immigrant Learning Center’s own Immigrant Entrepreneur Awardee for Life Science Business. But his influence extends well beyond that space into environmental conservationism, safeguarding refugees, mentoring and promoting STEM education, and building public understanding of America’s Sikhs, as you’ll hear in this week’s episode of JobMakers.

Guest:

Amarpreet Sawhney, Ph.D., is the Chairman and CEO OF Instylla Inc which is developing new liquid embolics for tumor embolization and hemostasis. He is also CEO of Rejoni Inc., which is developing products to prevent adhesions following gynecological interventions. Previously he was President and CEO of Ocular Therapeutix, Inc. (OCUL: NASDAQ) a company focused on unmet needs in ophthalmic drug delivery. He was also the Chairman of Augmenix, Inc. (acquired by Boston Scientific), Founder and CEO of Confluent Surgical (acquired by Covidien), the Chairman of MarketRx (acquired by Cognizant), a provider of pharmaceutical marketing and sales analytics and intelligence, technology founder of Focal, Inc. (acquired by Genzyme) and Access Closure Inc. (acquired by Cardinal Health). He holds over 120 patents, which form the basis for several first-of-a-kind medical devices that have helped over 5 million patients worldwide. He has founded eight companies, which account for over 4,000 jobs created and over $2 billion in revenue to date. Dr. Sawhney helps foster entrepreneurship by mentoring young innovators and creating companies through Incept, a medical device incubator. He is a member of the board of directors of EcoSikh, Axtria, Imperative care, Instylla, Rejoni, Tulavi, and Incept LLC. He is on the advisory board of the MIT museum. Dr. Sawhney is passionate about education, wildlife, and environmental causes, which he is involved in supporting through his family foundation. Dr. Sawhney has been recognized by several awards including being named the “Champions of Change” and “Outstanding American by Choice” awards by the Whitehouse, “Five most innovative Medical Device CEOs” by MassDevice, MassMedic best startup company award, Frost and Sullivan Product innovation award, MIT Global Indus Technovators Award, the E&Y regional entrepreneur of the year award, Mass High Tech All Star award, TiE Star award, the University of Texas Outstanding Young Engineering Graduate award, and the Indian Institute of Technology Delhi Distinguished Alumni award. Dr. Sawhney holds a Ph.D. and M.S. in Chemical Engineering from the University of Texas at Austin and a B.Tech. in Chemical Engineering from IIT Delhi.

Get new episodes of JobMakers in your inbox!

Browse recent episodes of Pioneer podcasts:

New England Short Circuit: Distorted Incentives Drive Energy Prices Up and Reliability Down

Joe Selvaggi talks with Travis Fisher from the Cato Institute about the rising costs and increasing fragility of the New England power grid, as green capacity incentives distract from neglected infrastructure.

UK’s Prof. Richard Holmes on Coleridge, the Ancient Mariner, & Poetry

Prof. Holmes delves into the life and literary legacy of Samuel Taylor Coleridge, one of the most significant poets of the Romantic era. Holmes offers a comprehensive overview of Coleridge's early education, highlighting how classical learning deeply influenced his worldview and writings.

Controlling Drug Prices: Costs and Benefits of Direct Negotiation with Big Pharma

Joe Selvaggi talks with Bill Smith, Director of the Life Sciences Initiative at Pioneer Institute, about the Inflation Reduction Act’s impact on drug pricing negotiations and its potential effects on drug development, consumers, and taxpayers.

NYT’s Anupreeta Das on Bill Gates, Microsoft, & Tech Billionaires

NYT’s South Asia correspondent, Anupreeta Das discusses how she became interested in writing her acclaimed biography, Billionaire, Nerd, Savior, King: Bill Gates and His Quest to Shape Our World, emphasizing Gates’ corporate and philanthropic influence on our era.

Harris’ Tax Vision: Policy & Politics

Joe Selvaggi talks with Tax Foundation Vice President William McBride about the details and potential effects of the tax policy proposed by Kamala Harris's presidential campaign

National Alliance’s Starlee Coleman on Public Charter Schools

Starlee Coleman discusses her role as CEO of the Texas Public Charter Schools Association, highlighting the growth of charter schools in Texas, as well as the broader efforts to expand school choice.

Digital Privacy Divide: Can Law Enforcement Google Where You’ve Been?

Joe Selvaggi talks with Cato Institute legal fellow Brent Skorup about the split in the court of appeals over the Constitution's 4th Amendment protections concerning law enforcement's search of location tracking data.

Houston Supt. Mike Miles & Urban School Reform

Mr. Miles reflects on his lifelong dedication to public service, starting as a soldier, then a diplomat, and later as an educational leader. He shares insights into his family background and formative experiences that shaped his commitment to serving the public.

Housing Bond Bill: Could Billions Better Bay State Cost of Living

Joe Selvaggi talks with Pioneer's Senior Housing Fellow, Andrew Mikula, about the recently passed $5.2 billion bond bill, discussing its key features and how it might impact the supply and cost of homes in Massachusetts.

Dr. David Heidler on Andrew Jackson & American Democracy

Dr. David Heidler discusses the transformative period of Jacksonian Democracy, from 1829 to 1837. He explores the political changes, sectionalism, and reforms that characterized the era, alongside the controversial figure of Andrew Jackson, whose volatile nature and strategic political management propelled his rise and image.

Ruinous Red Tape: Epic Cost of Unchecked Federal Rule Making

Joe Selvaggi discusses the emergence of the massive, costly, and rapidly growing register of federal rules and regulations with Competitive Enterprise Institute’s Wayne Crews.

MIT’s Nobel Winner Joshua Angrist on the Economics of Education & Charter Public Schools

Prof. Angrist explores the controversies and his motivations behind studying K-12 education, emphasizing what policymakers often overlook about education and labor markets. He discusses his groundbreaking research on charter schools, highlighting how his findings have influenced policymakers. Angrist also talks about his Nobel-winning work on the analysis of causal relationships in economics and the innovative research currently underway at Blueprint, his lab at MIT.